PRKN and neoplasm: Beyond metabolism, Hacd2 non-enzymatically binds PRKN (Parkin), stabilizing PKM2 to activate c-Myc-driven glycolysis, thereby activating c-Myc-driven glycolysis to promote tumor cell proliferation [4].